TransMedics Group, Inc.
TMDX
$122.28
$0.17160.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.95M | 35.46M | 32.64M | 3.00M | -10.20M |
| Total Depreciation and Amortization | 21.59M | 19.76M | 17.68M | 14.40M | 11.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.15M | 38.58M | 31.85M | 55.34M | 52.25M |
| Change in Net Operating Assets | -61.30M | -45.00M | -44.73M | -49.02M | -61.05M |
| Cash from Operations | 49.38M | 48.80M | 37.44M | 23.72M | -7.80M |
| Capital Expenditure | -112.61M | -129.74M | -157.96M | -217.48M | -195.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 441.00K | 441.00K | 441.00K | -14.89M | -14.89M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -27.21M | -27.21M |
| Cash from Investing | -112.17M | -129.30M | -157.52M | -259.58M | -237.20M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 460.00M |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -52.07M |
| Issuance of Common Stock | 22.72M | 22.87M | 22.61M | 16.27M | 6.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -14.62M |
| Cash from Financing | 22.72M | 22.87M | 22.61M | 16.27M | 399.65M |
| Foreign Exchange rate Adjustments | -5.00K | -536.00K | 443.00K | -120.00K | -53.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.07M | -58.16M | -97.02M | -219.71M | 154.59M |